Search research articles
Contact Us
Filters
Showing results (321-330 of 400) with videos related to
Page
of 40
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2011
Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion
Yirong Li, Martin Ligr, James P McCarron, et al.
Science Advances
|
May 16, 2025
<i>Ppp1r3b</i> is a metabolic switch that shifts hepatic energy storage from lipid to glycogen
Kate Townsend Creasy, Minal B Mehta, Carolin V Schneider, et al.
Nature Genetics
|
March 31, 2019
Transposable elements drive widespread expression of oncogenes in human cancers
Hyo Sik Jang, Nakul M Shah, Alan Y Du, et al.
Science Advances
|
September 12, 2020
Incomplete annotation has a disproportionate impact on our understanding of Mendelian and complex neurogenetic disorders
David Zhang, Sebastian Guelfi, Sonia Garcia-Ruiz, et al.
Clinical and Translational Medicine
|
November 14, 2023
A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis
Barbara Klughammer, Luca Piali, Alexandra Nica, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
August 7, 2025
Evaluating the Role of Faecal Calprotectin in Older Adults
Robert William Perry, Peter Foulser, David Zhang, et al.
JCI Insight
|
May 8, 2020
Signaling pathways predisposing to chronic kidney disease progression
Mohamad Zaidan, Martine Burtin, Jitao David Zhang, et al.
Arthritis and Rheumatism
|
December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.
International Journal of Molecular Sciences
|
December 15, 2019
Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype
Filip Roudnicky, Yanjun Lan, Max Friesen, et al.
American Heart Journal
|
May 26, 2021
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 400) with videos related to
Sort By:
Page
of 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2011
Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion
Yirong Li, Martin Ligr, James P McCarron, et al.
Science Advances
|
May 16, 2025
<i>Ppp1r3b</i> is a metabolic switch that shifts hepatic energy storage from lipid to glycogen
Kate Townsend Creasy, Minal B Mehta, Carolin V Schneider, et al.
Nature Genetics
|
March 31, 2019
Transposable elements drive widespread expression of oncogenes in human cancers
Hyo Sik Jang, Nakul M Shah, Alan Y Du, et al.
Science Advances
|
September 12, 2020
Incomplete annotation has a disproportionate impact on our understanding of Mendelian and complex neurogenetic disorders
David Zhang, Sebastian Guelfi, Sonia Garcia-Ruiz, et al.
Clinical and Translational Medicine
|
November 14, 2023
A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis
Barbara Klughammer, Luca Piali, Alexandra Nica, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
August 7, 2025
Evaluating the Role of Faecal Calprotectin in Older Adults
Robert William Perry, Peter Foulser, David Zhang, et al.
JCI Insight
|
May 8, 2020
Signaling pathways predisposing to chronic kidney disease progression
Mohamad Zaidan, Martine Burtin, Jitao David Zhang, et al.
Arthritis and Rheumatism
|
December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.
International Journal of Molecular Sciences
|
December 15, 2019
Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype
Filip Roudnicky, Yanjun Lan, Max Friesen, et al.
American Heart Journal
|
May 26, 2021
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Page
of 40